Aster DM Healthcare seeks govt approval for director appointment
Aster DM Healthcare Limited has initiated the regulatory process to obtain central government approval for appointing Dr. Mandayapurath Azad Moopen as Executive Director for the period from April 15, 2026 to May 28, 2026. The appointment and remuneration were approved by the Board on March 10, 2026, and by shareholders via postal ballot on April 12, 2026. The company published a notice on June 5, 2026, pursuant to Section 201 of the Companies Act, 2013, to formalize this application.
*this image is generated using AI for illustrative purposes only.
Aster DM Healthcare Limited has initiated the process to secure central government approval for the appointment of Dr. Mandayapurath Azad Moopen as Executive Director. The company published a notice to members on June 5, 2026, pursuant to Section 201 of the Companies Act, 2013, outlining its intention to apply for the necessary sanctions. This regulatory step is required to formalize the directorship and associated remuneration for the specified period.
The appointment, which covers the period from April 15, 2026 to May 28, 2026, was previously approved by the Board of Directors on March 10, 2026. Shareholders subsequently endorsed the proposal through a postal ballot conducted via electronic voting on April 12, 2026. The company is now moving to satisfy the final regulatory requirements under Sections 196, 197, and 201 of the Companies Act, read with Schedule V.
Key Details of the Appointment
The notice specifies that the application to the Central Government encompasses both the appointment of Dr. Moopen and the payment of his remuneration. The terms and conditions governing this role were established by the Board and ratified by the shareholders earlier this year.
| Particulars | Details |
|---|---|
| Appointee Name | Dr. Mandayapurath Azad Moopen |
| DIN | 00159403 |
| Role | Executive Director |
| Appointment Period | April 15, 2026 to May 28, 2026 |
| Board Approval Date | March 10, 2026 |
| Shareholder Approval Date | April 12, 2026 |
The publication of this notice in newspapers such as the Financial Express and AndhraJyothy serves as a formal intimation to the members regarding the company's compliance with the statutory provisions. The company has also made the information available on its official website.
Historical Stock Returns for Aster DM Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.61% | +5.19% | +3.14% | +20.63% | +30.54% | +407.22% |
Will the government approve Dr. Moopen's remuneration package as requested, or might modifications be imposed?
Does this brief executive directorship signal a longer-term strategic leadership transition for Aster DM Healthcare?
How will this appointment impact the company's operational strategy during the specified six-week period?
15
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
